BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22191397)

  • 1. ProAir(®) HFA delivers warmer, lower-impact, longer-duration plumes containing higher fine particle dose than Ventolin(®) HFA.
    McCabe JC; Koppenhagen F; Blair J; Zeng XM
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):104-9. PubMed ID: 22191397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Interval Between Actuations of Albuterol Hydrofluoroalkane Pressurized Metered-Dose Inhalers on Their Aerosol Characteristics.
    Berlinski A; Pennington D
    Respir Care; 2017 Sep; 62(9):1123-1130. PubMed ID: 28611228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach to study the pMDI plume using an infrared camera and to evaluate the aerodynamic properties after varying the time between actuations.
    Kunda NK; Hautmann J; Godoy SE; Marshik P; Chand R; Krishna S; Muttil P
    Int J Pharm; 2017 Jun; 526(1-2):41-49. PubMed ID: 28450164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a holding chamber on albuterol metered-dose inhaler product differences.
    Johnson JL; Guthrie D; Hyde J; Hanson T; Karlage K; Myrdal PB
    Ann Allergy Asthma Immunol; 2016 Sep; 117(3):246-50. PubMed ID: 27613457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies.
    Kerwin EM; Taveras H; Iverson H; Wayne D; Shah T; Lepore MS; Miller DS
    Clin Drug Investig; 2016 Jan; 36(1):55-65. PubMed ID: 26541599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plume Characteristics of Two HFA-Driven Inhaled Corticosteroid/Long-Acting Beta2-Agonist Combination Pressurized Metered-Dose Inhalers.
    Johal B; Murphy S; Tuohy J; Marshall J
    Adv Ther; 2015 Jun; 32(6):567-79. PubMed ID: 26100350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Inhalation Flow Rate on Mass-Based Plume Geometry of Commercially Available Suspension pMDIs.
    Moraga-Espinoza DF; Eshaghian E; Shaver A; Smyth HDC
    AAPS J; 2018 Jul; 20(5):84. PubMed ID: 30003443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica.
    Cheng YS; Fu CS; Yazzie D; Zhou Y
    J Aerosol Med; 2001; 14(2):255-66. PubMed ID: 11681657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler.
    Biswas R; Hanania NA; Sabharwal A
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):256-266. PubMed ID: 28157430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the efficiency of aerosol therapy with pressurised metered-dose inhalers through plastic spacers.
    Chuffart AA; Sennhauser FH; Wildhaber JH;
    Swiss Med Wkly; 2001 Jan; 131(1-2):14-8. PubMed ID: 11205181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Medication Velocity and Size Distribution from Pressurized Metered-Dose Inhalers by Phase Doppler Anemometry.
    Alatrash A; Matida E
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):501-513. PubMed ID: 27504720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma.
    Lumry W; Noveck R; Weinstein S; Barnhart F; Vandermeer A; Murray A; Reisner C
    Ann Allergy Asthma Immunol; 2001 Mar; 86(3):297-303. PubMed ID: 11289328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability in Delivered Dose from Pressurized Metered-Dose Inhaler Formulations Due to a Delay Between Shake and Fire.
    Hatley RH; Parker J; Pritchard JN; von Hollen D
    J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):71-79. PubMed ID: 27635793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Exploration of Factors Affecting
    Ruzycki CA; Martin AR; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2019 Dec; 32(6):405-417. PubMed ID: 31418632
    [No Abstract]   [Full Text] [Related]  

  • 16. Delivered Lung Dose and Aerodynamic Particle Size Distribution of Salbutamol Pressurized Metered Dose Inhaler After Living Under Patients' Realistic Retention Environments.
    Ammari WG; Khalil Mohammad M; Tayyem RF; Martin GP; Royall PG
    J Aerosol Med Pulm Drug Deliv; 2019 Dec; 32(6):386-395. PubMed ID: 31199708
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
    Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
    Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plume temperature emitted from metered dose inhalers.
    Brambilla G; Church T; Lewis D; Meakin B
    Int J Pharm; 2011 Feb; 405(1-2):9-15. PubMed ID: 21129465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D; Vicaut E; Lefrançois G;
    Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of extreme temperatures on drug delivery of albuterol sulfate hydrofluoroalkane inhalation aerosols.
    Hoye WL; Mogalian EM; Myrdal PB
    Am J Health Syst Pharm; 2005 Nov; 62(21):2271-7. PubMed ID: 16239418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.